G protein-coupled receptor (GRP78), the master resident ER chaperone, and its downstream target CCAAT/enhancer binding protein-α (C/EBP) homologous protein (CHOP) are involved in the development of NAFLD in obese animal models and patients [15,16]. Here, DDIT3 is linked to metabolic dysfunction-associated steatotic liver disease.